Professional Documents
Culture Documents
Genetic:
✓ Family history of Allergic Rhinitis
✓ Atopic Dermatitis
✓ Asthma
Antihistamines
⊳ Systemic Sneezing, For seasonal
(oral) rhinorrhea, allergic rhinitis,
itching, begin treatment
conjunctivitis before allergen
exposure.
Nonsedating
agents should be
tried first. If
ineffective or too
expensive for the
patient, the older
agents may be
used. (use oral for
seasonal) For
If curious pa mo sa pathophysiology, watch osmosis
perennial allergic
video
rhinitis, use an
intranasal steroid
CLINICAL PRESENTATION
as an alternative to
Signs and Symptoms of Allergic Rhinitis or in combination
Symptoms: with systemic
➢ The patient typically complains of clear rhinorrhea, antihistamines.
paroxysms of sneezing, nasal congestion,
⊳ Ophthalmic Conjunctivitis Logical addition to
postnasal drip, and pruritic eyes (itchy), ears, nose,
or palate. Late-phase reaction consists of primarily nasal steroids if
nasal congestion. ocular symptoms
are present.
Signs:
➢ For children, physical exam may reveal allergic ⊳ Intranasal Sneezing, Option for seasonal
shiners, a transverse nasal crease caused by rhinorrhea, allergic rhinitis.
repeated rubbing of the nose, and adenoidal nasal pruritus Warn patients of
breathing. Nasal turbinate's are coated with thin,
2
potential rhinitis
drowsiness.
Intranasal Rhinorrhea Reserve for use
Decongestants anticholinergic when above
⊳ Systemic Nasal Only needed when s therapies fail or
congestion nasal congestion is cannot be
present. tolerated.
GEN
PROBLEM IDENTIFICATION
4
Part 1
⊳ Create a list of the patient’s drug therapy problems.
- Gitagaan siya ug singulair, kay sige siyag take
antihistamine pero wa na ni effect sa iyaa
⊳ What information (signs, symptoms, laboratory values)
indicates the presence or severity of allergic rhinitis?
⊳ What additional information from the patient history is
needed to satisfactorily assess this patient?
OPTIMAL PLAN
Part 2
⊳ What drug, dosage form, dose, schedule, and duration
of therapy are best for this patient?
⊳ What alternatives would be appropriate if the initial
therapy fails?
OUTCOME EVALUATION
Part 3
⊳ What clinical and laboratory parameters are necessary
to evaluate the therapy for achievement of the desired
therapeutic outcome and to detect or prevent adverse
effects?
PATIENT EDUCATION
Part 4
⊳ What information should be provided to a patient
receiving an intranasal corticosteroid to enhance
compliance, ensure successful therapy, and
minimize adverse effects?
⊳ What information should be provided to a patient
receiving an ophthalmic antihistamine?